STOCK TITAN
  1. Home
  2. MBGRF

Moberg Pharma Stock Price, News & Analysis

MBGRF OTC

Company Description

Moberg Pharma (OTC: MBGRF) is a publicly traded pharmaceuticals: other company in the Health Technology sector.

This page provides a comprehensive overview of MBGRF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$0.0
Market Cap
18.7M
Shares outstanding

Latest News

View All
—

Moberg Pharma reports topline data in the North American phase 3 study and will regain rights to MOB-015 in EU

clinical trial
—

Moberg Pharma lowers expectations on primary endpoint in ongoing phase 3 trial following data in a subset of patients

clinical trial
—

Moberg Pharma receives SEK 336 million through TO 2 and directed issue to top guarantors - subscription rate in TO 2 of 98%

—

MOB-015 is launched in Sweden under the brand name Terclara- pharmacies report major demand for the new medication

—

MOB-015 is recommended for approval in EU: Moberg Pharma

—

Moberg Pharma and Padagis sign agreement for MOB-015 in Israel

Moberg Pharma has 10 recent news articles. Key topics include clinical trial. View all MBGRF news →

SEC Filings

View All

No SEC filings available for MBGRF.

Financial Highlights

View Full Financials
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

MBGRF Company Profile & Sector Positioning

Moberg Pharma (MBGRF) operates in the Pharmaceuticals: Other industry within the broader Health Technology sector and is listed on the OTC.